midwich cuckoo
18-02-2007, 02:51 AM
Peoples brains are changing. Is this caused by chemtrails?.
My parents, friends and I all suffer back pain, aching joints, headaches etc and we are sprayed with a lot of chemtrails.
Think of the reported health effects of chemtrails such as aching limbs and headaches when you read the following from the BBC. -
BBC News, Sunday, 18 February 2007
Back pain linked to brain changes
Chronic back pain is linked to physical changes in the brain, according to researchers in Germany.
A team found patients with the condition also had microstructural changes in the pain-processing areas of their brains.
The scientists said the work provided evidence that the condition was real and it could aid treatment research.
The research was presented at the Radiological Society of North America's annual meeting, in Chicago.
To study the condition, the researchers used a technique called diffusion tensor imaging (DTI) to look at the differences between sufferers' and healthy volunteers' brains.
They discovered the brains of patients with chronic back pain had a more complex and active microstructure compared with the healthy volunteers' brains.
The changes occurred in regions of the brain associated with pain-processing, emotion and stress response.
Cause or result?
Lead researcher Dr Jurgen Lutz, a radiologist at Ludwig-Maximilians University in Munich, Germany, said: "A major problem for patients with chronic pain is making their condition believable to doctors, relatives and insurance carriers. DTI could play an important role in this regard.
"With these objective and reproducible correlates in brain imaging, chronic pain may no longer be a subjective experience. For pain diagnosis and treatment, the consequences could be enormous."
However, the researchers said more research would be needed to determine whether the physical changes were a cause or result of the pain.
Co-author Gustav Schelling, from the Department of Anaesthesiology at Munich University, said: "It's difficult to know whether these are pre-existing changes in the brain that predispose an individual to developing chronic pain, whether ongoing pain creates the hyperactivity that actually changes the brain organisation, or if it is some mixture of both.
"DTI may help explain what's happening for some of these patients, and direct therapeutic attention from the spine to the brain."
Dr Alison McGregor, a back pain expert from Imperial College London, said: "Eighty percent of the population suffer from back pain at some point in their lives, and quite often you cannot find a physical cause for that."
She said the study added to a growing body of research that revealed chronic pain was associated with physical changes in the brain.
"We are gradually getting more of an understanding on whether the central nervous system is involved in back pain - however we are not really sure what the physical changes mean."
http://news.bbc.co.uk/1/hi/health/6369047.stm
mynameis
18-02-2007, 08:52 AM
http://www.flyana.com/skypoxia.html
------------------------------------------------------------------------------------------
Q:What happens if I breathe in Skydrol fluids?
A:Upper respiratory irritation, including nose and throat irritation and tracheitis and/or bronchitis, can occur from inhalation of a mist. People with asthma may have a more marked reaction.
If through some accident liquid Skydrol fluid is aspirated directly into the lungs, such as by swallowing a large amount and breathing in at the same time or by breathing in while vomiting, it is quite possible that chemical pneumonitis could occur. This occurs following deep aspiration of any foreign material into the lungs. We have never heard of this happening with the Skydrol fluids. The possibility of it happening under normal industrial conditions does not appear likely.
When mist or vapor is possible because of high pressure leaks or any leak hitting a hot surface, a respirator capable of removing organic vapors and mists should be worn.
Q: What is the proper first aid treatment for eye exposure to Skydrol fluid?
A: Solutia is not aware of any case of eye damage from exposure to Skydrol fluid. When the fluid gets into the eyes, it can cause severe pain, but the pain will subside as soon as the fluid is removed. First aid is washing with tap water, or a standard eye irrigation solution. Water alone will not do the whole job, but it is an important start. Finish the job by putting a few drops of sterile mineral oil in the eye. Sterile mineral oil is available from a pharmacy, and will dissolve any Skydrol fluid that remains in the eye after flushing with water. Milk is not recommended as an eye wash, because it is not sterile and can cause infections in the eye. Always remember to wear safety glasses or chemical goggles to prevent eye exposure when working around Skydrol.
-------------------------------------------------------------------------------------------------
CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY
DEPARTMENT OF PESTICIDE REGULATION
MEDICAL TOXICOLOGY BRANCH
SUMMARY OF TOXICOLOGY DATA
BIOBOR JF1
2,2-oxybis (4,4,6-trimethyl-1,3,2-dioxaborinane) [CC 792] combined with
2,2-(1-methyltrimethylenedioxy)bis-(4-methyl-1,3,2-dioxaborinane) [CC 2227]
2,2-oxybis(4,4,6-trimethyl-1,3,2-dioxaborinane)
Chemical Code # 000792, Tolerance # 50439
July 25, 2003
I. DATA GAP STATUS
Chronic Toxicity, rat: Data gap, no study on file
Subchronic, dermal, rabbit Data gap, upgradeable study, dermal irritation
Chronic Toxicity, dog: Data gap, no study on file
Oncogenicity, mouse: Data gap, no study on file
Oncogenicity, rat: Data gap, no study on file
Reproduction, rat: Data gap, no study on file
Reproduction, mouse: Data gap, no study on file
Teratology, rat: No data gap, possible adverse effect
Teratology, rabbit: Data gap, inadequate study, possible adverse effect indicated
Gene mutation: No data gap, no adverse effect
Chromosome: Data gap, inadequate study on file, no adverse effect indicated
DNA damage: Data gap, inadequate study, no adverse effect indicated
Neurotoxicity: Not required at this time
Toxicology one-liners are attached.
** indicates an acceptable study.
Bold face indicates a possible adverse effect.
Toxicology summary by Kishiyama and Gee, 7/25/03.
File name: T030725.
See also the "Reregistration Eligibility Document" of US EPA, dated June, 1993. There is
currently one product registered in California, Biobor JF.
1 See file Grouping.doc
DPR MEDICAL TOXICOLOGY BIOBOR° JF T030725 Page 2
II. TOXICOLOGY ONE-LINERS AND CONCLUSIONS
These pages contain summaries only. Individual worksheets may contain additional effects.
COMBINED, RAT
No study on file.
CHRONIC TOXICITY, RAT
No study on file.
CHRONIC TOXICITY, DOG
No study on file.
ONCOGENICITY, RAT
No study on file.
ONCOGENICITY, MOUSE
No study on file.
REPRODUCTION, RAT
No study on file.
TERATOLOGY, RAT
** 002 088735 Lemen, J. K. “Rat teratology Study with Biobor® JF.” (Hazleton
Laboratories America Incorporated, HLA Study No. 182-129, July 12, 1990.) BIOBOR® JF,
purity 95%, was administered by gavage at doses of 0 (corn oil), 100, 300, or 1000 mg/kg to 25
mated female Crl:CD®BR rats per group 6 through 15 of gestation. Test article was not corrected
for purity. Possible adverse effect: lower fetal weights and viability; increased incidence of soft
tissue variations (dilated ventricles of the brain and renal pelvic cavitation); fetal skeletal
variations (incomplete ossified and/or unossified skull, vertebrae, sternebrae, centra, ischium,
pubes, metacarpals, metatarsals); vertebral anomalies with and/or without associated rib anomalies
- malformations. Developmental NOEL = 100 mg/kg/day (lower fetal weight, visceral variations
and skeletal variations and malformations). Maternal NOEL = > 1000 mg/kg/day.
ACCEPTABLE. (Kishiyama and Gee, 7/16/03).
US EPA (1993): Developmental NOEL = 100 mg/kg/day; maternal NOEL = 300 mg/kg/day
(reduced weight gain at termination of study (possibly due to lower gravid uterine weight).
TERATOLOGY, RABBIT
DPR MEDICAL TOXICOLOGY BIOBOR° JF T030725 Page 3
002 088734 Lemen, J. K. “Rabbit teratology Study with Biobor® JF.” (Hazleton
Laboratories America Incorporated, HLA Study No.182-131, July 11, 1990.) BIOBOR® JF,
purity 100% (assumed), was administered by gavage at doses of 0 (corn oil), 25, 75, or 225 mg/kg
to 17 pregnant New Zealand White Rabbits/group on days 7 through 19 of gestation. No evidence
of maternal toxicity. Maternal NOEL = > 225 mg/kg/day. Possible adverse effects (fetuses) :
mid and high-dose groups had skeletal variations related to incomplete ossification and variability
in the number of ribs and prescaral vertebrae [5th sternebrae unossified, absent sternebra(e), and
7th cervical rib(s)]. There was no dose-related increase in visceral or skeletal malformations.
Developmental NOEL = 25 mg/kg/day. UNACCEPTABLE (rationale for dose selection was
not stated). Upgradeable. (Kishiyama and Gee, 7/16/03).
US EPA (1993): Maternal NOEL = 225 mg/kg/day, Developmental NOEL = 25 mg/kg/day
(ossification of sternebrae)
GENE MUTATION
** 004 114605 Lawlor, T.E. “Mutagenicity Test on Biobor® JF in the Ames
Salmonella/Microsome Reverse Mutation Assay.” (Hazleton Laboratories America, Inc., HLA
Study No.: 10630-0-401, June 11, 1990) Biobar® JF (95% purity) was tested at concentrations
of 0 (corn oil), 0.1, 0.5, 1, 5, 10, 50, and 100 μl/plate for mutagenicity using Salmonella
typhimurium strains TA98, TA100, TA1535, TA1537 and TA1538 by the plate incorporation
assay. There were triplicate plates per concentration with and without rat liver activation. There
were two trials. No significant increase of revertants was reported with Biobor ® exposure under
study conditions. ACCEPTABLE. (Kishiyama and Gee, 7/22/03).
The RED of US EPA lists a study with mouse lymphoma that is not on file with the Department.
The study is by Microbiological Associates, Lab number NO1-CP-41004, 1988.
CHROMOSOME EFFECTS
004 114604 Ivett, J. L. “Mutagenicity Test on Biobor® JF in the In Vivo Mouse Micronucleus
Assay.” (Hazleton Laboratories America, Incorporated, HLA Study No.: 10630-0-455, March
13, 1989.) Biobar® JF (lot HP 7322, purity not identified) was administered at doses of 0 (corn
oil), 500, 2500, or 5000 mg/kg via a single gavage to five ICR mice/sex/group. Mice were
sacrificed at 24, 48 or 72 hours post-dosing. One thousand polychromatic erythrocytes per
animal were scored for micronuclei and the ratio of normochromatic erythrocytes to PCEs
determined. The PCE value for high dose males (5000 mg/kg) was statistically significantly
higher at 48 hours but considered by the author as a statistical anomaly due to the low
micronucleus value in the control compared with the historical control range. Also, there was no
time course for an effect. Females did not show any increase in micronuclei. UNACCEPTABLE
(dosing material purity needs to be confirmed). Upgradeable. (Kishiyama and Gee, 7/22/03).
DNA DAMAGE
004 114606 Cifone, M. A. “Mutagenicity Test on Biobor® JF in the Rat Primary Hepatocyte
Unscheduled DNA Synthesis Assay.” (Hazleton Laboratories America, Inc., HLA Study No.:
10630-0-447, February 27, 1989.) Biobor® JF (lot # HP7322, purity not stated) was tested at
DPR MEDICAL TOXICOLOGY BIOBOR° JF T030725
Page 4
101 to 1010 μg/ml in Assay #2 and 50.6 to 380 μg/ml in a second assay for DNA damage by
measuring UDS in primary rat hepatocytes in vitro. The first trial was not completed due to poor
cell attachment. UDS was evaluated by autoradiography. There were triplicate coverslips per
concentration in each trial with 50 cells scored per coverslip for a total of 150 cells per
concentration. No significant changes in the nuclear labeling of rat primary hepatocytes.
Summary data only were presented. UNACCEPTABLE (the results from individual cultures and
the nuclear and cytoplasmic counts and test article purity were not included in the report).
Upgradeable. (Kishiyama and Gee, 7/23/03).
MISCELLANEOUS
Subchronic, Rabbit dermal
005 114609 Lemen, J. K. “13-Week Dermal Toxicity Study in Rabbits with Biobor® JF.”
(Hazleton Laboratories America, Inc., HLA Study No. 182-133, December 26, 1989.) Biobor®
JF (lot LH No. 24,064C, purity not given but assumed 100%) was administered at doses of 0, 105,
525, or 1050 mg/kg/day, 5 days/week for 13 weeks. Test material was applied undiluted to the
dorsal skin of 10 New Zealand rabbits/sex/group under occluded wrap. The site of treatment
application showed one or more signs of dermal irritation at all doses, including some in corn oil
controls. Dermal NOEL <105 mg/kg/day. Hematocrit and hemoglobin levels were decreased for
high dose females but not for males. There were no treatment-related effects on body weight,
food consumption, clinical chemistry, ophthalmology or histopathology other than skin.
Systemic NOEL for females = 525 mg/kg/day. UNACCEPTABLE. Upgradeable (confirmation
of purity of test article) (Kishiyama and Gee, 7/24/03).
-------------------------------------------------------------------
Avgas has a lower volatility than mogas (i.e. it does not evaporate as quickly), which can be important for high-altitude use and higher temperatures. The particular mixtures in use today are the same as when they were first developed in the 1950s and 1960s, and therefore the high-octane ratings are achieved by the addition of tetra-ethyl lead (TEL), a fairly toxic substance that was phased out for car use in most countries in the 1980s. The main petroleum component used in blending avgas is alkylate, which is essentially a mixture of various isooctanes, and some refineries also use some reformate.
Avgas is currently available in several grades with differing maximum lead concentrations. Since TEL is a rather expensive additive, a minimum amount of it is typically added to the fuel to bring it up to the required octane rating so actual concentrations are often lower than the maximum.
Jet fuel is not avgas. It is similar to kerosene and is used in turbine engines. It is also used in the few aircraft with diesel engines. Civilian aircraft use Jet-A, Jet-A1 or in severely cold climates Jet-B. There are other classification systems for military turbine and diesel fuel. See Jet fuel.
------------------------------------------------------------------------------
Covance
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Covance
Covance logo
Type Public (NYSE: CVD)
Founded 1997
Headquarters Princeton, New Jersey; facilities in 18 countries
Key people N/A
Industry Contract Research Organizations
Pharmaceutical
Products drug development services
laboratory animals
Revenue US$1.02 billion USD (2004)
Employees 7,000+ (2005)
Website www.covance.com Covance Video (http://youtube.com/watch?v=nJ-VEJzDl8U)
Covance Inc. (NYSE: CVD), formerly Hazleton Laboratories America, Inc., with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies, according to its own website, with annual revenues over $1 billion, global operations in 18 countries, and over 7,000 employees worldwide. It became a publicly traded independent business after being spun off by Corning, Inc. in 1997.
Under the name Covance Research Products Inc. (CRP), based in Denver, Pennsylvania, the company also deals in the import and sale of laboratory animals. It is the single largest importer of primates in the U.S. and the world's largest breeder of laboratory dogs. It owns two dog-breeding facilities, two primate centers and a rabbit-breeding facility.
The company is a leading provider of laboratory testing services to the environmental, food and nutritional supplement industries, as well as a provider of custom antibody products and services to the research community for neurological disorders. Covance offers cell type-specific marker antibodies for neuroscience and suites of products for both Alzheimer’s and Parkinson’s disease, as well as an online antibody store including phospho-specific and secondary antibodies.
The company has been the subject of controversy following allegations of primate abuse in its laboratories in Germany and the United States, and in connection with a potential outbreak of the Ebola virus.
Ebola virus
In November 1989 at the Hazleton (Covance) Primate Quarantine Unit in Reston, Virginia, lab monkeys were found to have carried Ebola virus from the Philippines. The U.S. Centers for Disease Control and Prevention intervened to eradicate the infected animals and burn the complex down, and avoided a potentially disastrous outbreak. Afterwards, in February 1990, a number of infected monkeys were shipped to Hazleton facilities in both Virginia and Texas. This strain was also found to be airborne. More Reston ebolavirus infected monkeys were discovered in 1992 in Siena, Italy and at the Texas Hazleton facility again in March 1996.
http://z10.invisionfree.com/Loose_Change_Forum/index.php?showtopic=3295
--------------------------------------------------------------------------------------------------------------
Bird flu found on eastern England poultry farm
03 Feb 2007 02:12:21 GMT
Source: Reuters
LONDON, Feb 3 (Reuters) - An outbreak of bird flu has been confirmed on a poultry farm in eastern England, the Environment, Food and Rural Affairs Department said.
Government veterinary experts were called to the farm near Lowestoft, in Suffolk county, late on Thursday and preliminary tests show the birds were killed by the H5 strain of avian flu, the department said in a statement on its Website late on Friday.
Further tests are under way to identify the strain more precisely, and restrictions are in place to stop the movement of birds to or from the site, it said.
The press agency Press Association said about 1,000 turkeys were thought to have died on the farm.
A wild swan found dead in Scotland in March 2006 had the highly pathogenic H5N1 version of the bird flu virus which can kill humans. It was thought to have caught the disease elsewhere, died at sea and been washed ashore in Scotland.
The H5N1 virus is known to have infected 270 people and killed at least 164 worldwide since 2003, most of them in Asia, and over 200 million birds have died from it or have been killed to prevent its spread.
------------------------------------------------------------------------------------------------
News Story link Reuters. (http://www.alertnet.org/thenews/newsdesk/L03223511.htm)
Other persuant links (http://z10.invisionfree.com/Loose_Change_Forum/index.php?showtopic=3316&st=0#entry11763343)